Specialty Chemical Stock Fixes Record Date For Stock Split; How Many Shares Will You Get After Feb 20?

The record date for Titan Biotech Limited's planned equity share subdivision (stock split) has been communicated to the exchanges. Friday, February 20, 2026 has been set as the record date to identify eligible shareholders for the stock split, according to the company's filing to the BSE.

One equity share with a face value of Rs 10 shall be split into five fully paid-up equity shares with a face value of Rs 2 each under the authorized corporate action. Titan Biotech intends to increase trading activity without changing shareholders' proportional ownership in the firm by reducing the face value from Rs 10 to Rs 2.

According to the announced split ratio in 1:5, investors who owned shares before the record date are automatically eligible for the revised share entitlement.

In other words, following the split, you will receive five shares for every share you already own. The market price changes correspondingly, so even if the number of shares grows fivefold, the total value of your investment stays the same.

For instance, you will have 500 shares of Titan Biotech after the split if you had 100 shares before February 20. Since stock splits promote liquidity, make shares more affordable for individual investors, and may boost trading volumes, this action remains always watchful for the market watchers.

Titan Biotech Stock Split Record Date

"We wish to inform you that pursuant to Regulation 42 of the Listing Regulations, the Company has fixed Friday, February 20, 2026, as the Record Date for the purpose of determining the eligibility of Members for the sub-division / Split of 1 (one) equity share of face value of Rs. 10/- (Rupees Ten) each, fully paid-up, into 5 (five) equity shares of face value of Rs. 2/- (Rupees Two) each, fully paid-up as approved by the Members of the Company through Postal Ballot on December 30, 2025." said Titan Biotech in a regulatory filing.

Titan Biotech Stock Split Details

In order to significantly expand the number of shares while lowering the face value per share, the corporation has proposed a subdivision (stock split) of its equity shares. Before the split, 1,00,00,000 equity shares with a face value of Rs 10 each made up the authorized share capital; after the subdivision, that number rose to 5,00,00,000 equity shares with a face value of Rs 2 apiece.

In a similar vein, the issued share capital increased to 4,13,18,500 equity shares of Rs 2 each following the subdivision from 82,63,700 equity shares of Rs 10 each before the split. With 82,63,700 equity shares of Rs 10 each prior to the split and 4,13,18,500 equity shares of Rs 2 each following the split, the subscribed and paid-up share capital corresponds to the issued capital.

Titan Biotech Target Price

"Titan Biotech stock price is bearish with strong resistance at 1154 on the Daily charts. A Daily close below support of 1020 could lead to a target of 857 in the near term," commented A R Ramachandran, part-time SEBI-registered Research Analyst, Tips2trades.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.